Price T Rowe Associates Inc Penumbra Inc Transaction History

Price T Rowe Associates Inc

  • $883 Billion
  • Q2 2025

A detailed history of Price T Rowe Associates Inc transactions in Penumbra Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 1,374,001 shares of PEN stock, worth $342 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,374,001
Previous 1,208,431 13.7%
Holding current value
$342 Million
Previous $323 Million 9.12%
% of portfolio
0.04%
Previous 0.04%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$253.22 - $299.78 $41.9 Million - $49.6 Million
165,570 Added 13.7%
1,374,001 $353 Million
Q1 2025

May 14, 2025
SELL
$237.28 - $303.76 $13.6 Million - $17.4 Million
-57,256 Reduced 4.52%
1,208,431 $323 Million
Q4 2024

Feb 14, 2025
SELL
$190.97 - $253.66 $137 Million - $183 Million
-719,571 Reduced 36.25%
1,265,687 $301 Million
Q3 2024

Nov 14, 2024
SELL
$163.64 - $210.12 $170 Million - $219 Million
-1,040,315 Reduced 34.38%
1,985,258 $386 Million
Q2 2024

Aug 14, 2024
SELL
$172.27 - $223.95 $43,067 - $55,987
-250 Reduced 0.01%
3,025,573 $545 Million
Q1 2024

May 15, 2024
SELL
$220.09 - $273.15 $17.3 Million - $21.5 Million
-78,767 Reduced 2.54%
3,025,823 $675 Million
Q4 2023

Feb 14, 2024
BUY
$181.44 - $260.22 $207 Million - $297 Million
1,140,807 Added 58.09%
3,104,590 $781 Million
Q3 2023

Nov 14, 2023
SELL
$240.69 - $338.77 $62.9 Million - $88.5 Million
-261,319 Reduced 11.74%
1,963,783 $475 Million
Q2 2023

Aug 14, 2023
BUY
$271.54 - $344.06 $10.9 Million - $13.8 Million
40,040 Added 1.83%
2,225,102 $766 Million
Q1 2023

May 15, 2023
BUY
$220.43 - $278.69 $246 Million - $311 Million
1,115,176 Added 104.23%
2,185,062 $609 Million
Q4 2022

Feb 14, 2023
BUY
$151.88 - $228.5 $6.2 Million - $9.32 Million
40,791 Added 3.96%
1,069,886 $238 Million
Q3 2022

Nov 14, 2022
SELL
$120.36 - $205.88 $24.3 Million - $41.6 Million
-202,034 Reduced 16.41%
1,029,095 $195 Million
Q2 2022

Aug 15, 2022
BUY
$116.09 - $227.33 $10.5 Million - $20.6 Million
90,749 Added 7.96%
1,231,129 $153 Million
Q1 2022

May 16, 2022
SELL
$187.51 - $283.98 $18.4 Million - $27.9 Million
-98,329 Reduced 7.94%
1,140,380 $253 Million
Q4 2021

Feb 14, 2022
BUY
$238.08 - $288.0 $2.71 Million - $3.28 Million
11,389 Added 0.93%
1,238,709 $356 Million
Q3 2021

Nov 15, 2021
SELL
$250.72 - $291.24 $6.99 Million - $8.12 Million
-27,876 Reduced 2.22%
1,227,320 $327 Million
Q2 2021

Aug 16, 2021
SELL
$235.0 - $310.7 $8.04 Million - $10.6 Million
-34,217 Reduced 2.65%
1,255,196 $344 Million
Q1 2021

May 17, 2021
SELL
$175.6 - $291.43 $15.8 Million - $26.2 Million
-89,999 Reduced 6.52%
1,289,413 $349 Million
Q4 2020

Feb 16, 2021
BUY
$174.98 - $272.83 $241 Million - $376 Million
1,379,412 New
1,379,412 $241 Million

Others Institutions Holding PEN

# of Institutions
507
Shares Held
29.7M
Call Options Held
266K
Put Options Held
59.2K
View Full List

About Penumbra Inc

PEN Quotes by TradingView
  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.42B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email